Inventor
Samuel R. Denmeade
Inventor
Ellicott City, MD, US
Overview
Patents· 23 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
C07KPeptides26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C07DHeterocyclic compounds7%
C12NMicroorganisms or enzymes7%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
C07CAcyclic or carbocyclic compounds3%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests3%
PatentTitleYear
10,967,046Albumin-proaerolysin prodrugs202110,596,226Albumin-proaerolysin prodrugs202010,369,113Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancer20199,492,560'Emetine derivatives, prodrugs containing same, and methods of treating conditions using same'20169,422,234'Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancer'20168,957,016'Tumor activated prodrugs'20158,822,406'Tumor activated prodrugs'20148,772,226'Methods and compositions for the detection of cancer'20148,669,231'Activation of peptide prodrugs by hK2'20148,450,280'Activation of peptide prodrugs by hK2'20138,258,256'Compositions and methods for the treatment of cancer'20127,906,477'Activation of peptide prodrugs by hK2'20117,838,266'Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer'20107,767,648'Tissue specific prodrugs'20107,745,395'Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer'20107,635,682'Tumor activated prodrugs'20097,468,354'Tissue specific prodrugs'20087,282,476'Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer'20077,053,042'Activation of peptide prodrugs by hK2'20066,545,131'Tissue specific prodrug'20036,504,014'Tissue specific prodrug'20036,410,514'Tissue specific prodrug'20026,265,540'Tissue specific prodrug'2001Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2001–2003Based in Baltimore, MD, US· patent location history
2002–2021Patents assigned to UNIV JOHNS HOPKINS (12)· patent assignee history
2003–2021Based in Ellicott City, MD, US· patent location history
2006–2016Patents assigned to DENMEADE SAMUEL R (7)· patent assignee history
2006–2015Patents assigned to ISAACS JOHN T (4)· patent assignee history
2006–2014Patents assigned to LILJA HANS (3)· patent assignee history
2007–2015Based in Ellicot City, MD, US· patent location history
2008–2015Patents assigned to GENSPERA INC (8)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV JOHNS HOPKINS | 12 | 2002–2021 |
| GENSPERA INC | 8 | 2008–2015 |
| DENMEADE SAMUEL Rself | 7 | 2006–2016 |
| ISAACS JOHN T | 4 | 2006–2015 |
| LILJA HANS | 3 | 2006–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Ellicott City, Maryland, US | 12 | 2003–2021 |
| Ellicot City, Maryland, US | 8 | 2007–2015 |
| Baltimore, Maryland, US | 3 | 2001–2003 |